Clinical Trial

Prospera Test Evaluation in Cardiac Transplant (ProTECT)

Study acronym: ProTECT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The ProTECT registry is an observational longitudinal, multi-center study observing patients undergoing heart transplant for whom Prospera testing is part of routine clinical care, who are enrolled within 60 days of heart transplantation.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-01-11; most recent amendment 2025-05-19.
Status change: Recruiting → Active, Not Recruiting 2024-03-19
Trial Details
NCT Number NCT05205551
Lead Sponsor Natera, Inc.
Conditions Heart Transplant Rejection
Enrollment 411 participants
Start Date 2021-10-01
Primary Completion 2026-10-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-22